DBV Technologies S.A.
VIASKIN Peanut Patch
peanut allergy
Resolved
7days ago
Phase 3 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 3 trial results for VIASKIN Peanut Patch in peanut allergy are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“positive phase 3 clinical results in the fourth quarter, that will both support the planned BLA submission for the VIASKIN Peanut Patch in children aged 4 to 7 years in the first half of 2026.”